Philadelphia Trust Co. Has $4.70 Million Stake in Oracle Co. (NYSE:ORCL)

Philadelphia Trust Co. reduced its stake in Oracle Co. (NYSE:ORCL) by 3.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 28,185 shares of the enterprise software provider’s stock after selling 1,140 shares during the period. Philadelphia Trust Co.’s holdings in Oracle were worth $4,697,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in ORCL. Fortis Capital Advisors LLC boosted its position in Oracle by 38.6% in the fourth quarter. Fortis Capital Advisors LLC now owns 10,368 shares of the enterprise software provider’s stock valued at $1,728,000 after buying an additional 2,885 shares in the last quarter. Petros Family Wealth LLC bought a new stake in shares of Oracle during the 4th quarter valued at about $499,000. Monetary Management Group Inc. grew its stake in Oracle by 0.7% during the fourth quarter. Monetary Management Group Inc. now owns 22,285 shares of the enterprise software provider’s stock worth $3,714,000 after purchasing an additional 150 shares during the period. Heritage Trust Co acquired a new position in Oracle in the fourth quarter valued at approximately $12,856,000. Finally, Oak Associates Ltd. OH increased its stake in shares of Oracle by 0.6% in the 4th quarter. Oak Associates Ltd. OH now owns 281,234 shares of the enterprise software provider’s stock valued at $46,865,000 after acquiring an additional 1,720 shares in the last quarter. 42.44% of the stock is owned by institutional investors.

Analysts Set New Price Targets

ORCL has been the subject of several recent research reports. JMP Securities restated a “market outperform” rating and set a $205.00 price objective on shares of Oracle in a report on Wednesday, January 22nd. Westpark Capital began coverage on Oracle in a report on Tuesday, April 1st. They issued a “buy” rating and a $195.00 target price for the company. Stifel Nicolaus lowered their price objective on shares of Oracle from $175.00 to $150.00 and set a “hold” rating on the stock in a research report on Tuesday, March 11th. Jefferies Financial Group decreased their target price on Oracle from $220.00 to $190.00 and set a “buy” rating for the company in a research report on Monday, March 31st. Finally, UBS Group reiterated a “market perform” rating on shares of Oracle in a research report on Tuesday, March 11th. Thirteen equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $178.65.

Insider Activity at Oracle

In related news, Director Naomi O. Seligman sold 2,000 shares of the firm’s stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $145.81, for a total transaction of $291,620.00. Following the completion of the transaction, the director now directly owns 34,630 shares of the company’s stock, valued at approximately $5,049,400.30. This trade represents a 5.46 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Safra Catz sold 345,174 shares of the business’s stock in a transaction on Friday, January 24th. The stock was sold at an average price of $185.56, for a total transaction of $64,050,487.44. Following the completion of the sale, the chief executive officer now owns 1,118,592 shares in the company, valued at approximately $207,565,931.52. The trade was a 23.58 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 2,448,328 shares of company stock worth $453,791,001. Corporate insiders own 42.20% of the company’s stock.

Oracle Stock Down 0.8 %

NYSE:ORCL opened at $132.27 on Friday. The firm has a market cap of $369.94 billion, a P/E ratio of 32.34, a P/E/G ratio of 3.46 and a beta of 1.22. Oracle Co. has a fifty-two week low of $112.78 and a fifty-two week high of $198.31. The company has a debt-to-equity ratio of 5.65, a quick ratio of 0.81 and a current ratio of 0.81. The firm has a 50-day simple moving average of $155.25 and a two-hundred day simple moving average of $167.63.

Oracle (NYSE:ORCL) last issued its earnings results on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.49 by ($0.02). The company had revenue of $14.13 billion during the quarter, compared to analysts’ expectations of $14.40 billion. Oracle had a return on equity of 133.25% and a net margin of 21.16%. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.41 EPS. Analysts predict that Oracle Co. will post 5 earnings per share for the current fiscal year.

Oracle Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Thursday, April 10th will be issued a dividend of $0.50 per share. This is a boost from Oracle’s previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a yield of 1.51%. The ex-dividend date is Thursday, April 10th. Oracle’s dividend payout ratio is currently 46.95%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.